1375 West Fulton Market
Suite 700
Chicago, IL 60607
United States
650 433 3000
https://talisbio.com
Sektor(en): Healthcare
Branche: Medical Devices
Vollzeitmitarbeiter: 99
Name | Titel | Zahlen | Ausgeübt | Geburtsjahr |
---|---|---|---|---|
Mr. Robert Kelley MBA | CEO & Director | 852,36k | N/A | 1972 |
Dr. Andrew A. Lukowiak Ph.D. | President & Chief Scientific Officer | 904,9k | N/A | 1973 |
Dr. Rustem F. Ismagilov Ph.D. | Co-Founder & Director | 53,95k | N/A | 1974 |
Ms. Rebecca Markovich | Interim Chief Financial Officer | 379,23k | N/A | 1974 |
Mr. Liang Li Ph.D. | Co-Founder and Director of Technology & Strategy | N/A | N/A | N/A |
Ms. Emily Faucette | Senior Vice President of Corporate Communications & Investor Relations | N/A | N/A | N/A |
Ms. Jill Green | Senior Vice President of Legal | N/A | N/A | N/A |
Mr. Matthew Pepe | Vice President of Human Resource | N/A | N/A | N/A |
Ms. Margaret Barrett M.S. | Controller | N/A | N/A | N/A |
Gillian Green | Company Secretary | N/A | N/A | N/A |
Talis Biomedical Corporation operates as a molecular diagnostic company, focusing on developing medical devices for infectious diseases and other conditions at the point of care in the United States. Talis Biomedical Corporation was incorporated in 2013 and is headquartered in Chicago, Illinois.
Talis Biomedical Corporations ISS Governance QualityScore, Stand 1. Juni 2024, lautet 9. Die grundlegenden Scores sind Audit: 9, Vorstand: 10, Shareholderrechte: 7, Kompensation: 9.